Back to Companies Directory
VERIFIED COMPANY DOSSIER

IKOMED Technologies Inc.

Verified Intel

IKOMED is Vancouver-based medical-device Technology Company. Our AEGIS is a shutter system that incorporates machine learning and image processing to reduce X-ray radiation in fluoroscopy by over 60% as proven in clinical-studies. Fluoroscopy is an X-Ray based imaging technology widely used to guide minimally-invasive procedures where catheters are inserted into patients’ bodies for treatment. These procedures reduce the need for surgery but expose patients and staff to large amounts of radiation. AEGIS has been cleared by the FDA and is sold commercially in the USA via a partner. ATMOS is a proprietary device for non-invasive treatment of emphysema, a type of COPD (Chronic- Obstructive-Pulmonary-Disease) using RF radiation. Emphysema is a debilitating disease, caused by smoking and other factors, and is one of the leading causes of death worldwide. Treatment is focused on alleviating symptoms with no cure available. The ATMOS device provides a full cure for the disease. It has been successfully proven on rodents, in collaboration with the UBC center for Heart and Lung Innovation (HLI) under the leadership of Prof Don Sin, and is now being tested on large animals on path to human trials.

IKOMED is Vancouver-based medical-device Technology Company. Our AEGIS is a shutter system that incorporates machine learning and image processing to reduce X-ray radiation in fluoroscopy by over 60% as proven in clinical-studies. Fluoroscopy is an X-Ray based imaging technology widely used to guide minimally-invasive procedures where catheters are inserted into patients’ bodies for treatment. These procedures reduce the need for surgery but expose patients and staff to large amounts of radiation. AEGIS has been cleared by the FDA and is sold commercially in the USA via a partner. ATMOS is a proprietary device for non-invasive treatment of emphysema, a type of COPD (Chronic- Obstructive-Pulmonary-Disease) using RF radiation. Emphysema is a debilitating disease, caused by smoking and other factors, and is one of the leading causes of death worldwide. Treatment is focused on alleviating symptoms with no cure available. The ATMOS device provides a full cure for the disease. It has been successfully proven on rodents, in collaboration with the UBC center for Heart and Lung Innovation (HLI) under the leadership of Prof Don Sin, and is now being tested on large animals on path to human trials.

Primary SectorGeneral Industry
Workforce Size11-50 Employees
Global HQVancouver, Canada
Total Capital RaisedBootstrapped / Private

Corporate Firmographics

Entity classification and operating profile

Industry
General
Company Type
Privately Held
Founded
2011
Employee Bracket
11-50
Estimated Revenue Range
Undisclosed

Geographic Coordinates

Headquarters address and regional territory

Street Address
1375 McLean Dr British Columbia Vancouver
City
Vancouver
Region / State
British Columbia
Postal Code
—
Country
Canada

Digital Presence & Footprint

Verified domains, socials, and directory profiles

Official Domainikomed.com
Visit Site
LinkedIn NetworkActive Profile
Open LinkedIn
OUTREACH AUTOMATION

Target Decision-Makers at IKOMED Technologies Inc.

Connect your mailboxes, set up your autonomous SDR Agent, and start generating hyper-personalized pipeline for accounts like IKOMED Technologies Inc. in minutes.

SYNTHESIZED INTEL

Frequently Asked Questions

Verified business inquiries and firmographic telemetry for IKOMED Technologies Inc..